MedPath

Cognitive Remediation Therapy and Schizophrenia

Not Applicable
Completed
Conditions
Schizophrenia
Interventions
Behavioral: non-CRT
Behavioral: cognitive remediation therapy
Registration Number
NCT01078129
Lead Sponsor
Hôpital le Vinatier
Brief Summary

Objectives:

The purpose of this study is to determine the impact of a new Cognitive Remediation Therapy (CRT) on cognition, social autonomy, symptoms and brain functioning in patients with schizophrenia.

Detailed Description

Methods:

In a 2 arms blind study versus sham,80 patients with schizophrenia were enrolled in a program consisting of 14 training sessions of 4 cognitive functions (attention/concentration, topological memory, logical reasoning, executive functions)by means REHACOM® software. Measures of cognitive functioning using the Cogtest® battery as well as social autonomy (Social Autonomy Scale, EAS) and schizophrenia symptoms (Positive And Negative Syndrome Scale, PANSS) were undertaken at the beginning and the end of the meetings of remediation.

Among those 80 participants, 30 patients to (15 active / 15 sham) were randomized to participate in an fMRI study in order to investigate the impact of such CRT program on brain functioning (n-back task before CRT and 3 months later).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
77
Inclusion Criteria
  • schizophrenia (DSM IV criteria)
  • remitted symptoms
  • french language
  • informed consent
Exclusion Criteria
  • addiction, neurological disease
  • only for second randomized patient participating in MRI study (n=30) : MRI counterindications

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
non-CRTnon-CRTno intervention
behavior therapy - CRTcognitive remediation therapybehavior program consisting of 14 training sessions of 4 cognitive functions (attention/concentration, topological memory, logical reasoning, executive functions) by means REHACOM® software
Primary Outcome Measures
NameTimeMethod
cognitive deficits (attention/concentration, topological memory, logical reasoning, executive functions)before and after CRT (3 months later)

standardised COGTEST battery (for details see cogtest.com). Cognitive performances were assessed 2 times : at inclusion and 3 months later (after CRT).

Secondary Outcome Measures
NameTimeMethod
brain functioning (fMRI)before and after CRT (3 months later)

fMRI during a n-back task, 2 times, before CRT and 3 months later. The 2 sub-groups of 15 patients will be compared with healthy subjects performances at the same task.

schizophrenia symptomsbefore CRT and 3 months later

standardised psychometric scale measuring Positive an Negative Symptoms (PANSS)

Trial Locations

Locations (1)

Hôpital le vinatier

🇫🇷

Bron, France

© Copyright 2025. All Rights Reserved by MedPath